Olanzapine-d8 – 500 µg

Brand:
Cayman
CAS:
1093380-13-2
Storage:
-20
UN-No:
Non-Hazardous - /

Olanzapine-d8 is intended for use as an internal standard for the quantification of olanzapine (Item No. 11937) by GC- or LC-MS. Olanzapine is an atypical antipsychotic that binds to dopamine D1, D2, and D4 receptors (Kis = 31, 11, and 27 nM, respectively) as well as the serotonin (5-HT) receptor subtypes 5-HT2A, 5-HT2C, and 5-HT3 (Kis = 4, 11, and 57 nM, respectively).{21347} It also binds to M1 muscarinic acetylcholine, α1-adrenergic, and histamine H1 receptors (Kis = 2, 19, and 7 nM, respectively). Olanzapine (0.5 mg/kg, i.p.) decreases immobility time in the forced swim test in non-stressed and prenatally-stressed rats, indicating antidepressant-like activity.{42431} It also decreases the number of avoidances made in the conditioned avoidance response test in rats when administered at doses of 0.5 and 1 mg/kg.{42432} Formulations containing olanzapine have been used in the treatment of schizophrenia and bipolar disorder.  

 

Available on backorder

SKU: 25447 - 500 µg Category:

Description

An internal standard for the quantification of olanzapine by GC- or LC-MS


Formal name: 2-methyl-4-(4-methyl-1-piperazinyl-2,2,3,3,5,5,6,6-d8)-10H-thieno[2,3-b][1,5]benzodiazepine

Synonyms: 

Molecular weight: 320.5

CAS: 1093380-13-2

Purity: ≥99% deuterated forms (d1-d8)

Formulation: A solid


Application|Mass Spectrometry||Product Type|Biochemicals|Analytical Standards||Product Type|Biochemicals|Isotopically Labeled Standards|Deuterium||Product Type|Biochemicals|Receptor Pharmacology||Research Area|Neuroscience|Behavioral Neuroscience|Bipolar Disorder||Research Area|Neuroscience|Behavioral Neuroscience|Depression||Research Area|Neuroscience|Behavioral Neuroscience|Schizophrenia & Psychosis